Edition:
United Kingdom

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

447JPY
24 Nov 2017
Change (% chg)

¥26 (+6.18%)
Prev Close
¥421
Open
¥416
Day's High
¥451
Day's Low
¥412
Volume
24,389,400
Avg. Vol
3,857,685
52-wk High
¥652
52-wk Low
¥219

Summary

Name Age Since Current Position

Yoshihiro Arai

46 2013 President, Representative Director

Toshio Miyashita

49 2015 Chief Financial Officer, Chief Director of Administration, Director

Yasuhiro Abe

49 2015 Independent Director

Norikazu Eiki

68 2016 Independent Director

Stanley Lau

62 2014 Independent Director

Masahiro Michisuji

81 2008 Independent Director

Biographies

Name Description

Yoshihiro Arai

Mr. Yoshihiro Arai has been serving as President and Representative Director in Solasia Pharma K.K. since February 2013. He joined the former entity of the Company in September 2007. He used to work for Pfizer Japan Inc. and Amgen Inc.

Toshio Miyashita

Mr. Toshio Miyashita has been serving as Chief Financial Officer, Chief Director of Administration and Director in Solasia Pharma K.K. since December 2015. He joined the Company in January 2014. He used to work for other eight companies, including INNOTECH CORPORATION, Sosei Group Corporation, Arakis Limited, HIBIKI Partners Co., Ltd., ATANI LIMITED and J-Pharma Co., Ltd.

Yasuhiro Abe

Mr. Yasuhiro Abe has been serving as Independent Director in Solasia Pharma K.K. since May 2015. He is also working for an affiliated company, ITOCHU Corporation. He used to work for Toda America Inc. and Toda Advanced Materials Inc.

Norikazu Eiki

Mr. Norikazu Eiki has been serving as Independent Director in Solasia Pharma K.K. since April 2016. He is also serving as Director in FunPep Co., Ltd., as well as Independent Director in Towa Pharmaceutical Co., Ltd. and AnGes MG, Inc., and working for CM Plus Corporation and another company. He used to work for Showa Shell Sekiyu K. K., Panasonic Electric Works Co., Ltd., Novartis Pharma K.K. and Bayer Yakuhin, Ltd.

Stanley Lau

Mr. Stanley Lau has been serving as Independent Director in Solasia Pharma K.K. since December 2014. He is also serving as Executive Partner in BizPro International LLC, as well as Senior Adviser in Wuxi SiFong Information Technology Co., Ltd. He used to work for Pfizer Corp. Hong Kong, Merck & Co., Schering Plough China Ltd., Pharmacia / Searle Asia, Baxter Healthcare International China, Haopy Pharmaceuticals Co., Ltd., China Biologic Products, Inc., Eddingpharm Ltd. and Amsino Medical Group.

Masahiro Michisuji

Mr. Masahiro Michisuji has been serving as Independent Director in Solasia Pharma K.K. since April 2008. He used to work for other seven companies, including MSD K.K., Pfizer Japan Inc., Bristol-Myers Squibb, Novartis Pharma K.K., Novartis International AG and Johnson Company, Limited.

Basic Compensation

Options Compensation